Clinical Trial Update: Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating renal oxygenation, oxygen consumption, and hemodynamic kinetics in type 2 diabetes treated with ertugliflozin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease
• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• Ertugliflozin (ertugliflozin)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Type 2 Diabetes Mellitus, Diabetic Kidney Disease | Phase 4 | Status: COMPLETED